NCT06082167 · Interventional trial
Study of Zanzalintinib (XL092) + Pembrolizumab vs Pembrolizumab in Subjects With PD-L1 Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Overall registry status Active not recruiting
Phase 2 · Phase 3
Conditions Head and Neck Squamous Cell Carcinoma
Delaware Valley sites
- Exelixis Clinical Site #158 · Camden, NJ · Camden County
First posted
Registry updated
Added to the directory